Related Experiment Video
Updated: Jun 5, 2025
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Pneumococcal Endocarditis, Sepsis, and Meningitis in an Immunocompromised Patient: A Case Study
Anastasios Nikolaos Panagopoulos1, Angelos Karagiannis2, Panagiotis M Sarris-Michopoulos1
1Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Streptococcus pneumoniae can cause severe infective endocarditis (IE), especially in untreated HIV patients. Early diagnosis and surgical intervention are crucial for survival and preventing complications like valve destruction.
Area of Science:
- Infectious Diseases
- Cardiology
- Immunology
Background:
- Pneumococcal infective endocarditis (IE) is rare but serious, particularly in immunocompromised individuals with untreated HIV.
- Untreated HIV significantly increases the risk of severe pneumococcal IE, leading to high morbidity and mortality from complications.
Observation:
- A 37-year-old male with untreated HIV presented with sepsis, meningitis, and mitral valve IE with large vegetations.
- The patient had a prior history of pneumococcal sepsis and meningitis, indicating a recurring susceptibility.
Findings:
- Pneumococcal IE in this patient led to acute mitral valve destruction and septic embolization.
- Prompt multidisciplinary team involvement was essential for operative management alongside antimicrobial therapy.
Implications:
- Early diagnosis and prompt surgical intervention are critical for improving outcomes in pneumococcal IE.
- Multidisciplinary collaboration and timely operative management are key to successful treatment and preventing complications.
- Vaccination in vulnerable populations may reduce the incidence of severe pneumococcal IE.
More Related Videos
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...